switching from tirzepatide to semaglutide dosage chart GLP-1 dose conversion and safe guide Switching between weight-loss medications -

& Gassama-Diagne, A

FDA Rybelsus label, 2025)

We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on gastrointestinal side effects in the label. Novo Nordisk added gastrointestinal events are "well-known side effects of the GLP-1 class" and when it comes to semaglutide, most GI side effects are mild to moderate in severity and short lasting

This treatment comes in the form of a once-daily oral tablet, allowing those in Staten Island to benefit from GLP-1 receptor agonist therapy without injections

When GLP-1 receptors in the brain and gut are activated, appetite decreases significantly

Ontaneda et al., 2021)